Safe and selective anti-parasite therapy targeting ribosome and glycosome function
Safe and selective anti-parasite therapy targeting ribosome and glycosome function
批准号:
451337
负责人:
Lubell William D
金额:
$64.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
未结题
起止时间:
2021-09-01 至 2026-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neglected tropical diseases (NTDs) due to protozoan infections are chronic, debilitating, and poverty-promoting maladies. Current treatments are failing due to spreading resistant strains, host toxicity, and incompatibility with rural health systems. Amon
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration
-
批准号:478746
-
项目类别:Operating Grants
-
资助金额:$37.62万
-
财政年份:2023
-
负责人:Lubell William D
-
依托单位:
Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation
-
批准号:468104
-
项目类别:Operating Grants
-
资助金额:$60.75万
-
财政年份:2022
-
负责人:Lubell William D
-
依托单位:
Allosteric Modulation of the Urotensin Receptor with Small-Molecule Peptide Mimics
-
批准号:407925
-
项目类别:Operating Grants
-
资助金额:$55.73万
-
财政年份:2019
-
负责人:Lubell William D
-
依托单位:
Azacyclopeptide Modulators of Immuno-metabolism to Treat Age-Related Macular Degeneration
-
批准号:396402
-
项目类别:Operating Grants
-
资助金额:$29.4万
-
财政年份:2018
-
负责人:Lubell William D
-
依托单位:
Allosteric modulation of the urotensin receptor with small molecules
-
批准号:321260
-
项目类别:Operating Grants
-
资助金额:$37.61万
-
财政年份:2015
-
负责人:Lubell William D
-
依托单位:
Targeting the interleukin-1 receptor for treating ischemic eye diseases
-
批准号:335739
-
项目类别:Operating Grants
-
资助金额:$27.36万
-
财政年份:2015
-
负责人:Lubell William D
-
依托单位:
Treatment of Preterm Birth with ProstaglandinF2alpha Receptor Modulators
-
批准号:317254
-
项目类别:Operating Grants
-
资助金额:$31.32万
-
财政年份:2014
-
负责人:Lubell William D
-
依托单位:
Treatment of Age Related Macular Degeneration with CD36 Receptor Modulators
-
批准号:295751
-
项目类别:Operating Grants
-
资助金额:$39.42万
-
财政年份:2013
-
负责人:Lubell William D
-
依托单位:
国内基金
海外基金
Anisomycin抑制T细胞的机制、应用及靶点
-
批准号:81172824
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:邢飞跃
-
依托单位: